{
  "success": true,
  "pagesUsed": [
    3,
    4,
    5,
    9,
    13,
    18,
    38,
    39,
    43,
    44,
    47,
    48,
    53,
    54,
    55
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "80fa29c7-d949-4057-ba75-2b676be881ca",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "50922667-f459-4dc9-84bd-ced090487e9a",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "6b70b540-cb8e-40ad-b6e1-0584359afa2c",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_2",
        "name": "Cycle 1 Day 1 Window",
        "type": {
          "id": "90f517c5-6dad-4055-b58f-b27043d42e14",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P3D",
        "valueLabel": "Day 3",
        "relativeToFrom": {
          "id": "2b5a18ad-719d-4cc2-9dd4-44badd039fe6",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "194a34f9-d698-443f-8061-4692473fc992",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P3D"
      },
      {
        "id": "timing_3",
        "name": "Pembrolizumab Cycle Frequency",
        "type": {
          "id": "2fec334b-f148-42b8-b3ba-0afc23e06f40",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "1a9d60db-ed38-4bf6-bb9c-549d351c2aa3",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "14c46841-9f8c-442a-a502-1fc412c0b7b2",
        "instanceType": "Timing",
        "windowLower": "-P3D",
        "windowUpper": "P3D"
      },
      {
        "id": "timing_4",
        "name": "Paclitaxel Cycle Frequency",
        "type": {
          "id": "b5900d71-eba2-46ee-917a-eb436e99a851",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "fa8bb973-caad-44ca-9cd2-049990ac3ed8",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "d8e6a274-5716-4572-a579-3a453c528fed",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Irinotecan Cycle Frequency",
        "type": {
          "id": "a300fe7e-2c93-4a9e-ad14-117e78489b36",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "0ff53e83-f9e1-489a-9b94-cd244402bafd",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "3f4b894d-9a36-49d6-ad32-896f20fe36c0",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Adverse Event Monitoring",
        "type": {
          "id": "1dfce2d8-85ec-4c0f-a20a-709f16dcd62e",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P30D",
        "valueLabel": "Day 30",
        "relativeToFrom": {
          "id": "af475770-85f0-4deb-8247-6135f37f93cb",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "61f993d5-a508-439d-bcdf-7515798fe6de",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P30D"
      },
      {
        "id": "timing_7",
        "name": "Serious Adverse Event Collection",
        "type": {
          "id": "35d7af27-a82c-4aa7-9a1e-59441444c3dd",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "051519cf-9d0b-4d9c-8de5-b59acd707025",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "773b7d60-1fc8-4dda-96e9-32ad29b2a75b",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P90D"
      },
      {
        "id": "timing_8",
        "name": "Contraception Window (Pembrolizumab)",
        "type": {
          "id": "17258294-a648-47bf-941d-a7095137c585",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P120D",
        "valueLabel": "Day 120",
        "relativeToFrom": {
          "id": "91b93ea9-e871-4134-adcf-d8f91f05608c",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "4cdf51c6-1d9b-47ad-8012-e2aeaab1eed6",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P120D"
      },
      {
        "id": "timing_9",
        "name": "Contraception Window (Chemotherapy)",
        "type": {
          "id": "247b82eb-3c47-4ae2-bfe7-7f494e0395e8",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P180D",
        "valueLabel": "Day 180",
        "relativeToFrom": {
          "id": "96585d9d-b6f7-4d24-9fd8-a290c180bb2f",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "392c5bf9-4142-4b2b-b27f-ef1bca871e67",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P180D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Complete Response (CR) Criteria",
        "instanceType": "Condition",
        "description": "Criteria for stopping treatment early due to response",
        "text": "Attainment of investigator-determined confirmed complete response (CR) after at least 8 treatments and 2 treatments beyond initial CR declaration."
      },
      {
        "id": "cond_2",
        "name": "Retreatment Eligibility",
        "instanceType": "Condition",
        "description": "Criteria for entering Second Course Phase",
        "text": "Radiographic disease progression after stopping for CR or 2-year completion, no interim cancer treatment, and meeting safety parameters."
      },
      {
        "id": "cond_3",
        "name": "Infusion Reaction Grade 2",
        "instanceType": "Condition",
        "description": "Criteria for restarting infusion",
        "text": "Symptoms resolve within 1 hour of stopping; restart at 50% original rate."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Transition to Second Course Phase",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_treatment",
        "toElementId": "epoch_retreatment",
        "text": "Subjects who experience radiographic disease progression after stopping for CR or 35 cycles of pembrolizumab."
      },
      {
        "id": "trans_2",
        "name": "Dose Modification for irAE",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Withhold or permanently discontinue pembrolizumab based on severity of immune-related adverse events per Table 3."
      },
      {
        "id": "trans_3",
        "name": "Discontinuation for Infusion Reaction",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Grade 3 or 4 infusion reaction or Grade 2 toxicity despite adequate premedication."
      },
      {
        "id": "trans_4",
        "name": "Rescue Therapy Rule",
        "instanceType": "TransitionRule",
        "transitionType": "Rescue Therapy",
        "text": "Radiation therapy to a symptomatic solitary lesion may be allowed after consultation with Sponsor."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Maximum Treatment Duration",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Pembrolizumab treatment may continue until 35 trial treatments (approx. 2 years)."
      },
      {
        "id": "exit_2",
        "name": "Pregnancy Discontinuation",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Immediate removal from study treatment if subject becomes pregnant."
      },
      {
        "id": "exit_3",
        "name": "Disease Progression",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Confirmed radiographic disease progression unless Sponsor approves continuation."
      },
      {
        "id": "exit_4",
        "name": "Administrative Termination",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Termination due to poor adherence to protocol, regulatory requirements, or inaccurate data recording."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "CR Discontinuation Decision",
        "timepointId": "cycle_8_plus",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision to stop treatment after achieving confirmed CR.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Retreatment Decision",
        "timepointId": "post_progression",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator discretion to retreat if no other cancer treatment was administered.",
        "conditionIds": [
          "cond_2"
        ]
      }
    ],
    "summary": {
      "timingCount": 9,
      "conditionCount": 3,
      "transitionRuleCount": 4,
      "exitCount": 4
    }
  }
}